The Hartford Healthcare Fund Class Y (HGHYX)
| Fund Assets | 837.48M |
| Expense Ratio | 1.03% |
| Min. Investment | $250,000 |
| Turnover | 40.00% |
| Dividend (ttm) | 2.05 |
| Dividend Yield | 4.25% |
| Dividend Growth | -31.51% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 11, 2025 |
| Previous Close | 47.50 |
| YTD Return | -2.48% |
| 1-Year Return | 12.81% |
| 5-Year Return | 13.64% |
| 52-Week Low | 38.92 |
| 52-Week High | 50.78 |
| Beta (5Y) | 0.67 |
| Holdings | 88 |
| Inception Date | May 1, 2000 |
About HGHYX
The Hartford Healthcare Fund Class Y is a mutual fund dedicated to achieving long-term capital appreciation by investing primarily in the global healthcare sector. Managed by Wellington Management Company LLP, the fund allocates at least 80% of its assets to equity securities of companies involved in various healthcare industries, including pharmaceuticals, biotechnology, medical devices, medical services, managed care, and health information services. This broad approach encompasses both established and emerging segments within the healthcare field, allowing the fund to capture diverse growth opportunities. The fund is classified as an institutional share class, with a minimum investment requirement of $250,000 and an expense ratio of 1.03%. Its portfolio is diversified across market capitalizations but is notably weighted toward large and giant cap healthcare firms such as Eli Lilly and UnitedHealth Group. The Hartford Healthcare Fund Class Y has approximately 100 holdings and distributes dividends annually, providing exposure to both domestic and international healthcare innovations. Its role in the financial market centers on offering targeted sector exposure, facilitating diversification for investors seeking participation in the growth and resilience of the global healthcare industry.
Performance
HGHYX had a total return of 12.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.75%.
Top 10 Holdings
47.71% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.16% |
| Merck & Co., Inc. | MRK | 5.76% |
| Johnson & Johnson | JNJ | 5.09% |
| UnitedHealth Group Incorporated | UNH | 4.66% |
| AbbVie Inc. | ABBV | 3.86% |
| Intuitive Surgical, Inc. | ISRG | 3.52% |
| Danaher Corporation | DHR | 3.07% |
| Abbott Laboratories | ABT | 3.07% |
| Edwards Lifesciences Corporation | EW | 2.84% |
| Cencora, Inc. | COR | 2.68% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 11, 2025 | $1.40315 | Dec 12, 2025 |
| Dec 27, 2024 | $0.14994 | Dec 30, 2024 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |